<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
        </div>
        <div class="card-body">
                <p>BACKGROUND: Genome-wide measures of gene expression can identify patterns of gene activity that subclassify tumours and might provide a better means than is currently available for individual risk assessment in patients with lymph-node-negative breast cancer. METHODS: We analysed, with Affymetrix Human U133a GeneChips, the expression of 22000 transcripts from total RNA of frozen tumour samples from 286 lymph-node-negative patients who had not received adjuvant systemic treatment. FINDINGS: In a training set of 115 tumours, we identified a 76-gene signature consisting of 60 genes for patients positive for oestrogen receptors (ER) and 16 genes for ER-negative patients. This signature showed 93% sensitivity and 48% specificity in a subsequent independent testing set of 171 lymph-node-negative patients. The gene profile was highly informative in identifying patients who developed distant metastases within 5 years (hazard ratio 5.67 [95% CI 2.59-12.4]), even when corrected for traditional prognostic factors in multivariate analysis (5.55 [2.46-12.5]). The 76-gene profile also represented a strong prognostic factor for the development of metastasis in the subgroups of 84 premenopausal patients (9.60 [2.28-40.5]), 87 postmenopausal patients (4.04 [1.57-10.4]), and 79 patients with tumours of 10-20 mm (14.1 [3.34-59.2]), a group of patients for whom prediction of prognosis is especially difficult. INTERPRETATION: The identified signature provides a powerful tool for identification of patients at high risk of distant recurrence. The ability to identify patients who have a favourable prognosis could, after independent confirmation, allow clinicians to avoid adjuvant systemic therapy or to choose less aggressive therapeutic options.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M2083">M2083</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:10579">ncbigene:10579</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2286">ncbigene:2286</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:101928104">ncbigene:101928104</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4134">ncbigene:4134</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:51093">ncbigene:51093</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:32">ncbigene:32</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10256">ncbigene:10256</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:397">ncbigene:397</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:960">ncbigene:960</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2116">ncbigene:2116</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:51131">ncbigene:51131</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:23595">ncbigene:23595</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:824">ncbigene:824</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8510">ncbigene:8510</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:678">ncbigene:678</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1846">ncbigene:1846</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3606">ncbigene:3606</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9840">ncbigene:9840</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:51280">ncbigene:51280</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9148">ncbigene:9148</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4747">ncbigene:4747</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:81577">ncbigene:81577</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3983">ncbigene:3983</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2055">ncbigene:2055</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10559">ncbigene:10559</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8741">ncbigene:8741</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8637">ncbigene:8637</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:161">ncbigene:161</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:26529">ncbigene:26529</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:636">ncbigene:636</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:718">ncbigene:718</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7940">ncbigene:7940</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M2083&#39;, name=&#39;WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN&#39;), definition=&#39;BACKGROUND: Genome-wide measures of gene expression can identify patterns of gene activity that subclassify tumours and might provide a better means than is currently available for individual risk assessment in patients with lymph-node-negative breast cancer. METHODS: We analysed, with Affymetrix Human U133a GeneChips, the expression of 22000 transcripts from total RNA of frozen tumour samples from 286 lymph-node-negative patients who had not received adjuvant systemic treatment. FINDINGS: In a training set of 115 tumours, we identified a 76-gene signature consisting of 60 genes for patients positive for oestrogen receptors (ER) and 16 genes for ER-negative patients. This signature showed 93% sensitivity and 48% specificity in a subsequent independent testing set of 171 lymph-node-negative patients. The gene profile was highly informative in identifying patients who developed distant metastases within 5 years (hazard ratio 5.67 [95% CI 2.59-12.4]), even when corrected for traditional prognostic factors in multivariate analysis (5.55 [2.46-12.5]). The 76-gene profile also represented a strong prognostic factor for the development of metastasis in the subgroups of 84 premenopausal patients (9.60 [2.28-40.5]), 87 postmenopausal patients (4.04 [1.57-10.4]), and 79 patients with tumours of 10-20 mm (14.1 [3.34-59.2]), a group of patients for whom prediction of prognosis is especially difficult. INTERPRETATION: The identified signature provides a powerful tool for identification of patients at high risk of distant recurrence. The ability to identify patients who have a favourable prognosis could, after independent confirmation, allow clinicians to avoid adjuvant systemic therapy or to choose less aggressive therapeutic options.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;15721472&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10579&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2286&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;101928104&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4134&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;51093&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;32&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10256&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;397&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;960&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2116&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;51131&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23595&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;824&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8510&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;678&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1846&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3606&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9840&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;51280&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9148&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4747&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;81577&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3983&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2055&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10559&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8741&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8637&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;161&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;26529&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;636&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;718&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7940&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Arthur Liberzon&#39;], &#39;exact_source&#39;: [&#39;Table 2: ER-positive group, Cox &lt; 0&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>